评估患者样品中GFAP状态的改进方法

本文公开了评估受试者的胶质纤维酸性蛋白(GFAP)状态的改进方法(例如用作创伤性脑损伤的度量或用于其它临床原因)。 Disclosed herein are improved methods of assessing ubiquitin carboxy-terminal hydrolase Ll (UCH-LI) status in a subject (such as for example, as a measure of traumatic brain injury or for other clinical reasons). Also disclosed herein are met...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 25.08.2023
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:本文公开了评估受试者的胶质纤维酸性蛋白(GFAP)状态的改进方法(例如用作创伤性脑损伤的度量或用于其它临床原因)。 Disclosed herein are improved methods of assessing ubiquitin carboxy-terminal hydrolase Ll (UCH-LI) status in a subject (such as for example, as a measure of traumatic brain injury or for other clinical reasons). Also disclosed herein are methods of assessing a subject's glial fibrillary acid protein (GFAP) and UCH-L1 status in subject (such as, for example as a measure of traumatic brain injury or for other clinical reasons).
Bibliography:Application Number: CN20178061647